SCHEMBL2474613

SCHEMBL2474613

C#CCNCC(C)C(F)Cc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.53
CYP2D6 P10635 3/20 0.53
TSHR P16473 2/20 0.53
CYP3A4 P08684 1/20 0.53
MAOB P27338 7/20 0.43
MAOA P21397 5/20 0.43
ADRA2A P08913 1/20 0.43
ADRA2B P18089 1/20 0.43
ADRA2C P18825 1/20 0.43
ADRA1A P35348 1/20 0.43
SNCA P37840 1/20 0.43
OPRK1 P41145 1/20 0.43
PKM P14618 1/20 0.43
MAPK1 P28482 1/20 0.42
KDM4E B2RXH2 1/20 0.42
TAAR1 Q96RJ0 3/20 0.40
SLC18A2 Q05940 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2477319 0.82 CYP1A2 (0.57) CYP1A2CYP2D6TSHRCYP3A4MAOB
SCHEMBL2480261 0.78 MAOA (0.40) CYP1A2CYP2D6TSHRCYP3A4MAOB
SCHEMBL2476229 0.78 MAOA (0.40) CYP1A2CYP2D6TSHRCYP3A4MAOB
SCHEMBL2477757 0.76 CYP1A2 (0.50) CYP1A2CYP2D6TSHRCYP3A4MAOB
SCHEMBL2471461 0.76 CYP1A2 (0.50) CYP1A2CYP2D6TSHRCYP3A4MAOB
Desmethylselegiline SCHEMBL27813455 0.73 CYP1A2 (0.93) CYP1A2CYP2D6TSHRCYP3A4ADRA2B
SCHEMBL3469029 0.71 CSNK1E (0.49) CYP1A2CYP2D6TSHRCYP3A4MAOB
SCHEMBL5794231 0.69 TAAR1 (0.55) CYP1A2CYP2D6TSHRCYP3A4MAOB
Rnordeprenyl SCHEMBL2477570 0.69 CYP1A2 (1.00) CYP1A2CYP2D6TSHRCYP3A4ADRA2B
Desmethylselegiline SCHEMBL4543249 0.69 CYP1A2 (1.00) CYP1A2CYP2D6TSHRCYP3A4ADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2388245-B1 Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors PIRAMAL IMAGING SA (CH) 2017-07-12 EP claimed
EP-2374779-A1 Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors Bayer Pharma Aktiengesellschaft (DE) 2011-10-12 EP disclosed
EP-2217549-A2 COMPOUNDS FOR USE IN IMAGING, DIAGNOSING, AND/OR TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM OR OF TUMORS Bayer Schering Pharma Aktiengesellschaft (DE) 2010-08-18 EP disclosed
WO-2009052970-A2 COMPOUNDS FOR USE IN IMAGING, DIAGNOSING, AND/OR TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM OR OF TUMORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-04-30 WO disclosed